Inventor · disambiguated record
Masahiro Hasegawa
Also filed as: HASEGAWA MASAHIRO
8 granted patents·3 pending applications·63 citations·filing 1989–2025
84Inventor score
Files withOTSUKA PHARMA CO LTD8IMMUNO BIOLOGICAL LAB CO LTD1KOBAYASHI HIROKO1TAISHO PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
11 records- 0195US11564885B2Centanafadine pharmaceutical formulations, and methods of making and using sameOTSUKA PHARMA CO LTD·Filed 2022·Granted Jan 31, 2023·12 cites·33 claims
- 0294US11759426B2Centanafadine pharmaceutical formulations, and methods of making and using sameOTSUKA PHARMA CO LTD·Filed 2022·Granted Sep 19, 2023·5 cites·30 claims
- 0393US11980690B2Centanafadine pharmaceutical formulations, and methods of making and using sameOTSUKA PHARMA CO LTD·Filed 2023·Granted May 14, 2024·2 cites·29 claims
- 0488US12370144B2Centanafadine pharmaceutical formulations, and methods of making and using sameOTSUKA PHARMA CO LTD·Filed 2024·Granted Jul 29, 2025·0 cites·27 claims
- 0585US12156941B2Centanafadine pharmaceutical formulations, and methods of making and using sameOTSUKA PHARMA CO LTD·Filed 2024·Granted Dec 3, 2024·0 cites·30 claims
- 0684US5274085AProcess for preparing erythromycin A oxime or a salt thereofTAISHO PHARMACEUTICAL CO LTD·Filed 1989·Granted Dec 28, 1993·44 cites·9 claims
- 0783US2025319030A1Centanafadine pharmaceutical formulations, and methods of making and using sameOTSUKA PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 0873US2024415774A1Delamanid-containing compositionOTSUKA PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0959US2021251902A1Delamanid-containing compositionOTSUKA PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 1055US7981672B2Monoclonal antibody and use thereofIMMUNO BIOLOGICAL LAB CO LTD·Filed 2007·Granted Jul 19, 2011·0 cites·13 claims
- 1142US8329414B2Monoclonal antibody and use thereofKOBAYASHI HIROKO·Filed 2011·Granted Dec 11, 2012·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Masahiro Hasegawa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →